txt

HB 253: "An Act classifying certain substances as schedule IIA controlled substances; and providing for an effective date."

00                             HOUSE BILL NO. 253                                                                          
01 "An Act classifying certain substances as schedule IIA controlled substances; and                                       
02 providing for an effective date."                                                                                       
03 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF ALASKA:                                                                
04    * Section 1. AS 11.71.150(e) is amended to read:                                                                   
05            (e)  Schedule IIA includes, unless specifically excepted or unless listed in                                 
06       another schedule, any material, compound, mixture, or preparation which contains any                              
07       quantity of the following substances having a stimulant effect on the nervous system:                             
08                 (1)  amphetamine, its salts, optical isomers, and salts of its optical                                  
09       isomers;                                                                                                          
10                 (2)  methamphetamine, its salts, isomers, and salts of its isomers;                                     
11                 (3)  methylphenidate;                                                                                   
12                 (4)  phenmetrazine and its salts;                                                                       
13                 (5)  fenethylline;                                                                                      
14                 (6)  N-ethylamphetamine;                                                                                
01                 (7)  3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-                                      
02       alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, and MDEA;                                       
03                 (8)  N-hydroxy-3,4-methylenedioxyamphetamine, also known as N-                                          
04       hydroxy-alpha-methyl-3,4-(methylenedioxy)phenethylamine, and N-hydroxy MDA;                                       
05                 (9)  4-methylaminorex, also known as 2-amino-4-methyl-5-phenyl-2-                                       
06       oxazoline;                                                                                                        
07                 (10)  N,N-dimethylamphetamine, also known as N,N,alpha-                                                 
08       trimethylybenzencethaneamine or N,N,alpha-trimethylphenethyline, its salts, optical                               
09       isomers, and salts of optical isomers;                                                                        
10                 (11)  cathinone;                                                                                    
11                 (12)  methcathinone, its salts, optical isomers, and salts of optical                               
12       isomers;                                                                                                      
13                 (13)  4-methylmethcathinone, also known as mephedrone, its salts,                                   
14       isomers, and salts of isomers;                                                                                
15                 (14)  3,4-methylenedioxypyrovalerone, also known as MDPV, its                                       
16       salts, isomers, and salts of isomers;                                                                         
17                 (15)  substituted cathinones, including any compound, except                                        
18       bupropion or a compound listed in another schedule, structurally derived from                                 
19       2-amino-1-phenyl-1-propanone by modification in any of the following ways:                                    
20                      (A)  by substitution in the phenyl ring to any extent with                                     
21            alkyl, alkoxy, alkylenedioxy, haloalkyl, hydroxyl, or halide substituents,                               
22            whether or not further substituted in the phenyl ring by one or more other                               
23            univalent substituents;                                                                                  
24                      (B)  by substitution at the 3-position with an alkyl                                           
25            substituent;                                                                                             
26                      (C)  by substitution at the nitrogen atom with alkyl or                                        
27            dialkyl groups or by inclusion of the nitrogen atom in a cyclic structure.                               
28    * Sec. 2. This Act takes effect immediately under AS 01.10.070(c).